REGENERON PHARMACEUTICALS, INC. — Director's Dealing 2016

Dec 19, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: REGENERON PHARMACEUTICALS INC (REGN)
CIK: 0000872589
Period of Report: 2016-12-16

Reporting Person: Van Plew Daniel P (EVP & General Mgr Industrial O)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-12-16	Non-Qualified Stock Option (right to buy)	$381.92	A	34000	Acquired	2026-12-16	Common Stock (34000)	Direct

Footnotes

F1: The stock option award vests in four equal annual installments, commencing one year after the date of grant.